avandaryl

How long does Glimepiride and Rosiglitazone Maleate stay in your body?

The elimination half-life of glimepiride and rosiglitazone maleate is about 5 hours (label mean 5.3 hours in adults, ± 4.1 hours — variation between people is wide) — the time it takes the body to clear about half of it. As a rule of thumb, a medicine is mostly gone after roughly 4 to 5 half-lives, though this varies from person to person with age and kidney or liver function. The 5.3-hour figure comes from single-dose adult data cited in the label's pediatric section; glimepiride does not build up in the blood with once-daily dosing. Glimepiride is fully broken down by CYP2C9 into M1, a metabolite that in animals has about one-third of glimepiride's blood-sugar-lowering activity (the label says it is unclear whether M1 matters clinically in humans) and M2, which is inactive. The label does not give a number for M1's half-life, but it states that in kidney impairment glimepiride's own terminal half-life does not change while the half-lives of M1 and M2 get longer — with severe impairment (creatinine clearance under 20 mL/min) showing 2.3-fold higher M1 and 8.6-fold higher M2 exposure, which is why hypoglycemia risk rises in kidney disease rather than because the parent drug lingers. In adults over 65 there was no meaningful pharmacokinetic difference (AUC about 13% lower, weight-adjusted clearance about 11% higher than in younger patients). Effects of liver impairment are unknown — the label states glimepiride has not been adequately studied in hepatic impairment. Taking propranolol alongside it lengthens glimepiride's half-life by about 15%. There is no extended-release glimepiride in the US; it is sold as immediate-release tablets and in fixed-dose combinations (for example with pioglitazone), which do not change glimepiride's half-life.

This is general information, not medical advice. It doesn’t tell you when a drug test would read negative (tests detect substances for different, often longer, windows) or when it’s safe to take another dose — ask your pharmacist or prescriber. Source: Glimepiride tablets — FDA prescribing information (Accord Healthcare), Sections 8.4 and 12.3.

Frequently asked questions

How much does Avandaryl cost?

Nobody can tell you what you will pay — your price is set by your insurer's formulary, your deductible and the pharmacy's markup, and none of those are published. What IS published is what the pharmacy paid to acquire it: about $0.91 for 30, per the CMS NADAC survey. Treat that as the floor, not the quote — ask the pharmacist for the cash price as well as your copay, because for cheap generics the cash price often wins.

Is there a coupon or discount for Avandaryl?

pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Avandaryl. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.

Who makes Avandaryl?

Avandaryl is marketed by Sb Pharmco. You can see Sb Pharmco's full profile, rating, and other products on pharmaranks.

Is Avandaryl a brand-name or generic drug?

Avandaryl is a brand-name product with the active ingredient Glimepiride and Rosiglitazone Maleate.

Is Avandaryl available over the counter?

No. Avandaryl is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.

What forms does Avandaryl come in?

Avandaryl is currently marketed as tablet, per the FDA's National Drug Code Directory.

Is Avandaryl FDA-registered?

Avandaryl is on record with the U.S. FDA under application number NDA021700. You can verify this on its official FDA label.